Yehuda |
1996 |
100 adults with probable AD |
n-3 and n-6 fatty acids |
4 weeks |
Modest improvement in short-term memory and quality of life |
Chiu |
2008 |
46 adults with MCI or AD |
n-3 fatty acids |
24 weeks |
Improvement in clinician rating of cognitive function |
Terano |
1999 |
20 elderly adults with VaD |
DHA supplementation |
1 year |
Modest improvement in MMSE and Hasegawa’s dementia rating scale after 6 months, but no group differences after 1 year |
van de Rest |
2008 |
321 healthy adults ≥ 65 years of age |
EPA + DHA |
26 weeks |
No group differences |
Freund-Levi |
2006 |
204 adults with AD |
n-3 fatty acids |
6 months |
No group differences with only modest improvements among a subgroup of mildly impaired patients |
Sano |
1997 |
341 patients with moderate AD |
Selegiline or alpha-tocopherol (vitamin e) |
2 years |
Slowed rates of cognitive decline in treatment group relative to placebo |
Petersen |
2005 |
769 patients with MCI |
Vitamin E supplements or Donepezil |
3 years |
Both treatments showed slower rates of conversion to AD during the first year and this effect was most pronounced among individuals with the APOE-4 genotype. No group differences after 3 years |
Balk |
2007 |
Meta-analysis of 14 RCTs |
B6, B12, and Folate |
Range: 5 weeks – 1 year |
Equivocal findings across a range of doses and administrations |
Malouf & Grimley |
2008 |
Meta-analysis of 8 RCTs |
Folate supplementation with and without B12 |
Range: 2–3 years |
No evidence that increasing folate and B12 levels improves cognitive function |
Malouf & Areosa |
2003 |
Meta-analysis of 3 RCTs |
B12 |
Range: 3 months – 1 year |
No evidence that increasing B12 improves cognitive function |
Malouf & Grimley |
2003 |
Meta-analysis of 2 RCTs |
B6 |
Range: 12 weeks – 1 year |
No evidence that increasing B6 levels improves cognitive function |
Kang |
2008 |
2,009 women > 65 years of age with cardiac disease |
B6, B12, and folic acid |
5.5 years |
No overall group difference. Subgroup analyses showed that women with low B vitamin levels exhibited preserved cognitive function relative to controls |
Witte |
2009 |
50 normal or overweight, older adults |
Caloric restriction or unsaturated fatty acids |
3 months |
Caloric restriction increased verbal memory and these improvements were correlated with decreased levels of fasting insulin and C-reactive protein |
Martin |
2007 |
48 overweight adults, aged 25 – 50 years |
Caloric restriction with or without exercise and a low-calorie diet |
6 months |
No change in cognitive function |
Halyburton |
2007 |
93 overweight or obese adults |
Low-carbohydrate, high-fat diet |
8 weeks |
No clinically significant change in cognitive function |